Laser Treatment for Postmenopausal Genital Atrophy

Uncontrolled pilot study suggests this approach merits more study.

Genital atrophy (also known as genitourinary syndrome of menopause [GSM]) is common, progressive, and can adversely affect sexual function and quality of life. In a manufacturer-funded study, menopausal women with complaints suggestive of GSM who were not receiving treatment were recruited at two U.S. centers. Participants received three office-based treatments with a C0₂ laser system at 6-week intervals (each treatment took <2 minutes and did not require analgesia or anesthesia). Laser energy was transmitted through a vaginal probe. Women were instructed that they could resume sexual activity ≥3 days after each treatment.

Among 30 participants (mean age, 59), 27 completed the treatments. As self-reported with an 11-point visual analogue sca…

Reviewing Author

Andrew M. Kaunitz, MD

Disclosures

RoyaltiesUpToDate

Grant/Research SupportMerck, Mithra, Medicines360

Editorial BoardsContraception; Menopause; Contraceptive Technology Update; OBG Management; Medscape OB/GYN & Women’s Health

Andrew M. Kaunitz, MD

Disclosures

RoyaltiesUpToDate

Grant/Research SupportMerck, Mithra, Medicines360

Editorial BoardsContraception; Menopause; Contraceptive Technology Update; OBG Management; Medscape OB/GYN & Women’s Health

Laser Treatment for Postmenopausal Genital Atrophy

Topics

Reviewing Author